AtriCure IncNASDAQ:ATRC
- LAST PRICE22.8100
- TODAY'S CHANGE (%)0.2000 (0.8846%)
- Bid / Lots22.7900/ 1
- Ask / Lots22.8300/ 4
- Open / Previous Close22.7000 / 22.6100
- Day Range
- 52 Week Range
- Volume52,520
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ATRC |
|---|---|---|
| 09:32 ET | 3218 | 22.77 |
| 09:38 ET | 100 | 22.63 |
| 09:39 ET | 1750 | 22.7513 |
| 09:41 ET | 100 | 22.68 |
| 09:48 ET | 100 | 22.79 |
| 09:50 ET | 100 | 22.68 |
| 09:54 ET | 120 | 22.68 |
| 09:56 ET | 4855 | 22.86 |
| 09:57 ET | 203 | 22.89 |
| 09:59 ET | 899 | 22.89 |
| 10:01 ET | 2000 | 22.945 |
| 10:03 ET | 1100 | 23.02 |
| 10:06 ET | 200 | 23.04 |
| 10:08 ET | 400 | 23.02 |
| 10:12 ET | 216 | 23.0591 |
| 10:21 ET | 1910 | 22.93 |
| 10:24 ET | 208 | 22.8977 |
| 10:26 ET | 418 | 22.845 |
| 10:28 ET | 300 | 22.86 |
| 10:30 ET | 100 | 22.82 |
| 10:32 ET | 600 | 22.83 |
| 10:33 ET | 400 | 22.87 |
| 10:35 ET | 855 | 22.82 |
| 10:46 ET | 100 | 22.76 |
| 10:53 ET | 100 | 22.745 |
| 10:55 ET | 817 | 22.76 |
| 11:00 ET | 500 | 22.72 |
| 11:02 ET | 200 | 22.74 |
| 11:04 ET | 800 | 22.77 |
| 11:06 ET | 627 | 22.81 |
| 11:09 ET | 863 | 22.785 |
| 11:11 ET | 1604 | 22.82 |
| 11:13 ET | 220 | 22.82 |
| 11:15 ET | 1000 | 22.83 |
| 11:18 ET | 412 | 22.82 |
| 11:20 ET | 400 | 22.82 |
| 11:24 ET | 100 | 22.82 |
| 11:29 ET | 1958 | 22.82 |
| 11:33 ET | 400 | 22.76 |
| 11:40 ET | 300 | 22.74 |
| 11:42 ET | 452 | 22.71 |
| 11:44 ET | 1500 | 22.745 |
| 11:45 ET | 700 | 22.78 |
| 11:47 ET | 449 | 22.73 |
| 11:49 ET | 200 | 22.755 |
| 11:51 ET | 100 | 22.78 |
| 11:54 ET | 400 | 22.8 |
| 12:00 ET | 900 | 22.825 |
| 12:02 ET | 500 | 22.81 |
Apr 23, 2024
DJ AtriCure Raised to Outperform From Perform by Oppenheimer, from 7:51AM ET on Tuesday Apr 23, 2024 by Dow Jones
7:51AM ET on Tuesday Apr 23, 2024 by Dow Jones
Apr 18, 2024
AtriCure Announces Launch of the cryoSPHERE(R) + Probe for Post-Operative Pain Management, from 8:00AM ET on Thursday Apr 18, 2024 by Dow Jones
8:00AM ET on Thursday Apr 18, 2024 by Dow Jones
Apr 10, 2024
Press Release: AtriCure to Announce First Quarter 2024 Financial Results, from 8:03AM ET on Wednesday Apr 10, 2024 by Dow Jones
8:03AM ET on Wednesday Apr 10, 2024 by Dow JonesAtriCure to Announce First Quarter 2024 Financial Results, from 8:00AM ET on Wednesday Apr 10, 2024 by Dow Jones
8:00AM ET on Wednesday Apr 10, 2024 by Dow JonesDJ AtriCure Price Target Maintained With a $46.00/Share by Needham, from 5:43AM ET on Wednesday Apr 10, 2024 by Dow Jones
5:43AM ET on Wednesday Apr 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
AtriCure Inc | 1.1B | -34.7x | --- |
Artivion Inc | 845.5M | -27.3x | --- |
Novocure Ltd | 1.3B | -6.4x | --- |
Figs Inc | 817.3M | 39.4x | --- |
Establishment Labs Holdings Inc | 1.3B | -15.9x | --- |
UFP Technologies Inc | 1.6B | 36.2x | +24.81% |
Company Information
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Contact Information
- Headquarters
- 7555 Innovation WayMASON, OH, United States 45040
- Phone
- 513-755-4100
- Fax
- 513-755-4567
Executives
- Independent Chairman of the Board
- B. Kristine Johnson
- President, Chief Executive Officer, Director
- Michael Carrel
- Chief Financial Officer
- Angela Wirick
- Chief Operating Officer
- Douglas Seith
- Chief Human Resource Officer
- Deborah Yount
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.1B |
|---|---|
Revenue (TTM) | $399.2M |
Shares Outstanding | 48.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.42 |
EPS | $-0.66 |
Book Value | $9.81 |
P/E Ratio | -34.7x |
Price/Sales (TTM) | 2.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6.68% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
